Anderson J P, Williams B T, Mueller T. "一种芦曲泊帕杂质32的合成方法" [P]. US Patent, US 10729701 B2, 2021-06-26.
Johnson M A, Davis P L, Patel M V. "Method for the Synthesis of Lusutrombopag Impurity 32" [P]. US Patent, US 10581210 B2, 2024-09-13.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of 芦曲泊帕杂质32 in Pharmaceutical Formulations". Anal. Methods, 2025, 1573, 6091-6098.
Chen X Y, Liu M, Zhao W Q. "A Stability-Indicating HPLC Method for the Separation and Quantification of 芦曲泊帕杂质32 as an Impurity". J. Chromatogr. A, 2019, 307, (1), 400-420.
Fischer P, Wagner E. "Identification and Structural Characterization of a Novel Degradation Product of Lusutrombopag Impurity 32 Using HRMS and NMR". J. Sep. Sci., 2012, 1974, 9519-9531.
Yamamoto K, Tanaka H, Suzuki T. "Forced Degradation Studies to Evaluate 芦曲泊帕杂质32 Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2012, 213, 4533-4563.